Published in J Geriatr Cardiol on September 01, 2015
Denominator changes may obscure results from single-well assays: β3-adrenoceptor ligand-induced changes of cell number as example. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation (2006) 5.91
Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation (2001) 3.54
Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation (2001) 3.01
Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol (2004) 2.53
Life history of eNOS: partners and pathways. Cardiovasc Res (2007) 2.53
Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (2005) 2.47
Nitric oxide in the pathogenesis of vascular disease. J Pathol (2000) 2.10
The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J (2002) 2.09
Glucocorticoids and cardiovascular disease. Eur J Endocrinol (2007) 2.02
Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) (2007) 1.87
Molecular mechanisms underlying the activation of eNOS. Pflugers Arch (2009) 1.84
Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest (2002) 1.80
Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. J Biol Chem (2009) 1.72
Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res (2008) 1.53
Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A (1999) 1.41
Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol (2009) 1.40
Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells. J Biol Chem (2009) 1.20
Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci (2013) 1.19
Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation (2002) 1.17
Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol (2013) 1.15
Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med (2008) 1.13
Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther (2010) 1.08
Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol (2010) 1.07
Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol (2006) 1.05
Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des (2009) 1.02
Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells. Cell Death Dis (2011) 1.00
Resveratrol and endothelial nitric oxide. Molecules (2014) 0.90
Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide (2013) 0.90
Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene. Nitric Oxide (2004) 0.90
Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells. Basic Res Cardiol (2012) 0.88
Inflammation, glucocorticoids and risk of cardiovascular disease. Nat Clin Pract Rheumatol (2008) 0.84
Pharmacological prevention of eNOS uncoupling. Curr Pharm Des (2014) 0.82
Structure-activity relationship of staurosporine analogs in regulating expression of endothelial nitric-oxide synthase gene. Mol Pharmacol (2000) 0.78
Dexamethasone upregulates Nox1 expression in vascular smooth muscle cells. Pharmacology (2014) 0.78
The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol (2016) 0.82
Restoration of perivascular adipose tissue function in diet-induced obese mice without changing bodyweight. Br J Pharmacol (2017) 0.78
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol (2017) 0.77
Effects of resveratrol on eNOS in the endothelium and the perivascular adipose tissue. Ann N Y Acad Sci (2017) 0.75
Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol (2016) 0.75